Brain+ AS (OCSE:BRAINP) Asset Impairment Charge : kr0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS Asset Impairment Charge?

Brain+ AS's Asset Impairment Charge for the six months ended in Dec. 2023 was kr0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.

Brain+ AS Asset Impairment Charge Historical Data

The historical data trend for Brain+ AS's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS Asset Impairment Charge Chart

Brain+ AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Brain+ AS Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Asset Impairment Charge	Get a 7-Day Free Trial			-	-	-	-	-

Brain+ AS Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Brain+ AS Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Brain+ AS's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Brain+ AS (OCSE:BRAINP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kobmagergade 53, 3rd Floor, Copenhagen, DNK, DK-1150

Website

https://www.brain-plus.com

Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS (OCSE:BRAINP) Headlines

No Headlines